PORTFOLIO NEWS eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and avelumab in Microsatellite Stable Colorectal Cancer October 4, 2017 Read More » Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd. September 19, 2017 Read More » FLX Flexing Against Suppression August 10, 2017 Read More » Constellation Pharmaceuticals Appoints Adrian Senderowicz, M.D., as Senior Vice President and Chief Medical Officer July 18, 2017 Read More » eFFECTOR Therapeutics Presents Phase I Data on EFT508, Its Lead Product Candidate, at ASCO 2017 June 5, 2017 Read More » Jigar Raythatha Rejoins Constellation Pharmaceuticals as President and CEO May 25, 2017 Read More » Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group February 15, 2017 Read More » Tenaya Therapeutics Launches with the Goal of Curing Heart Disease December 6, 2016 Read More » Arcus Aims to Build an Immuno-Oncology Powerhouse to Offer a Rational Approach to Combination Therapy September 19, 2016 Read More » Kallyope Inc. Launches with $44m Series A Financing to Harness the Potential of the Gut-Brain Axis December 10, 2015 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and avelumab in Microsatellite Stable Colorectal Cancer October 4, 2017 Read More »
Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd. September 19, 2017 Read More »
Constellation Pharmaceuticals Appoints Adrian Senderowicz, M.D., as Senior Vice President and Chief Medical Officer July 18, 2017 Read More »
eFFECTOR Therapeutics Presents Phase I Data on EFT508, Its Lead Product Candidate, at ASCO 2017 June 5, 2017 Read More »
Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group February 15, 2017 Read More »
Arcus Aims to Build an Immuno-Oncology Powerhouse to Offer a Rational Approach to Combination Therapy September 19, 2016 Read More »
Kallyope Inc. Launches with $44m Series A Financing to Harness the Potential of the Gut-Brain Axis December 10, 2015 Read More »
